1974
DOI: 10.1007/bf00268516
|View full text |Cite
|
Sign up to set email alerts
|

Destruction of low efficiency markers is a slow process occurring at a heteroduplex stage of transformation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

4
70
0

Year Published

1974
1974
2010
2010

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 122 publications
(74 citation statements)
references
References 19 publications
4
70
0
Order By: Relevance
“…Bacterial Strains-The pneumococcal strains used in this study were the encapsulated serotype 2 D39 strain (18) and its unencapsulated derivative DP1004 (19). The FP228 strain, a DP1004 mutant deleted for pfbB (spr0075), has been described previously (17).…”
Section: Methodsmentioning
confidence: 99%
“…Bacterial Strains-The pneumococcal strains used in this study were the encapsulated serotype 2 D39 strain (18) and its unencapsulated derivative DP1004 (19). The FP228 strain, a DP1004 mutant deleted for pfbB (spr0075), has been described previously (17).…”
Section: Methodsmentioning
confidence: 99%
“…S. pneumoniae Rxl (43,56), D39 (2,43), WU2 (9,14), A66 (2,8), DBL5 (66), EF3296 (8), BG9163 (8), WG44.1 (46,67), and JY2008 (67) have been previously described. JY180 is a PspA-negative derivative of strain D39 obtained by transformation with DNA from WG44.1 and selection for the erythromycin resistance marker located inpspA (this study; 67).…”
Section: Materuils and Methodsmentioning
confidence: 99%
“…In those studies, the donor DNA was prepared from the type 3 encapsulated strain A66. A66 was obtained from H. P. Bernheimer, and Rx1 was obtained from W. R. Guild (21). The responses to synthetic Rx1 pheromone peptide (TANA Labs, Houston, Tex.)…”
mentioning
confidence: 99%